A new potential biomarker for Parkinson’s

Researchers at Duke University have recently presented data on a new potential biomarker for Parkinson’s.


Our first pipeline project of research

Our first project from our Research Pipeline Acceleration Programme is now underway. Professor Michael Schwarzchild is investigating evidence needed to determine if three iLCT-evaluated compounds are ready to progress into clinical trials for people with Parkinson’s.


News Research news

2023 Tom Isaacs Award honours Dr Natasha Fothergill-Misbah 

Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Natasha Fothergill-Misbah, Research Associate at Newcastle University, as the winner of the 2023 Tom Isaacs Award. The award was presented to Natasha in Newcastle, as part of the annual Grand Challenges in Parkinson’s…


Webinars Webinars

NoSilverBullet4PD Webinar: How Parkinson’s impacts a woman’s life

In this upcoming webinar on Monday 9 October, the No Silver Bullet 4 Parkinson’s team will be joined by Parkinson’s advocates Richelle Flanagan and Annelien Oosterbaan to discuss the challenges and stigmas women with Parkinson’s often face before and after receiving a diagnosis. It is…


New research exploring ethnic diversity in Parkinson’s

A recent study from the Global Parkinson’s Genetic Program found a novel genetic risk factor for Parkinson’s in people of African ancestry. This finding once again brings to light the ongoing need for improving diversity in Parkinson’s research.